Director exercised or converted 92 BIO derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Sep 6, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Sep 9, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001924980-26-000004
Filed / recordedSep 9, 2026, 10:47 PM UTCAdded to OQROOct 6, 2026, 4:40 PM UTC Data qualityVerified: identifiers matched exactly IssuerBIO-RAD LABORATORIES, INC. Reporting personSchwartz Allison SecurityRestricted Stock Units TableDerivative (Table II) Transaction dateSep 6, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Around the same time
Traded Sep 5 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Traded Sep 5 · filed 4 days later
Routine share withholding; mechanical by default.
Traded Sep 6 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.